Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fisca

RICHMOND HILL, ON / ACCESSWIRE / December 15, 2021 / Helix BioPharma Corp. (TSX:HBP), (" Helix " or the " Company "), a clinical-stage biopharmaceutical company developing unique therapies in the field

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Krzysztof Saczek , Slawomir Majewski , Heman Chao , Drug Administration , Company The Board , Helix Biopharma Corp , Company Interim Condensed Financial , Nasdaq , Company Scientific Advisory Board , Toronto Stock Exchange , Company Phase Ib , Company Statements Of Financial Position , Helix Biopharma , Scientific Advisory Board , Interim Chief Executive Officer , Consulting Management , Financial Position , Net Loss , Comprehensive Loss , Interim Condensed Financial Statements , Looking Statements , Annual Information Form , Helix , Iopharma , Orp , Nnounces , Iscal , 022 , First , Quarter , Results ,